Canadian radiopharmaceutical firm DraxImage has filed an application for its sestamibi kit with European regulatory authorities.
The offering is a generic kit for the preparation of Tc-99m sestamibi for injection, according to the DraxImage parent Draxis Health of Mississauga, Ontario.
By AuntMinnie.com staff writers
July 25, 2007
Related Reading
Draxis unveils management changes, July 20, 2007
Draxis posts Q2 earnings estimate, July 20, 2007
Draxis hires DeChambre for business development, May 29, 2007
Draxis to join Nasdaq Biotechnology Index, May 16, 2007
Draxis grows Q1 revenues, net income, May 10, 2007
Copyright © 2007 AuntMinnie.com